Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA retires to think about food

WASHINGTON - Now that it has held three meetings to listen to public concerns about genetically engineered foods, the question is whether the FDA must take some action to satisfy its critics. A tea leaf reading, based on questions the agency asked its panels of guest experts, suggests that one course of action would be for FDA to expand the range of safety tests it recommends that companies conduct on GE products as well as making its existing consultation process mandatory.

Short of requiring

Read the full 833 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE